Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 56 of 56 results for cryotherapy

  1. Endometrial cryotherapy for menorrhagia (IPG157)

    We have moved interventional procedures guidance 157 to become HealthTech guidance 101. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  2. Cryotherapy for renal cancers (IPG207)

    This guidance has been updated and replaced by NICE HealthTech guidance 269 and HealthTech guidance 271.

  3. Cryotherapy for chronic rhinitis (IPG771)

    We have moved interventional procedures guidance 771 to become HealthTech guidance 692. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  4. Percutaneous cryotherapy for renal cancer (IPG402)

    Interventional procedures, IPG402 - Issued: July 2011 --> We have moved interventional procedures guidance 402 to become HealthTech guidance 269. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  5. Laparoscopic cryotherapy for renal cancer (IPG405)

    Interventional procedures, IPG405 - Issued: August 2011 --> We have moved interventional procedures guidance 405 to become HealthTech guidance 271. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  6. Cryotherapy for recurrent prostate cancer (IPG119)

    We have moved interventional procedures guidance 119 to become HealthTech guidance 71. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  7. Cryotherapy for malignant endobronchial obstruction (IPG142)

    We have moved interventional procedures guidance 142 to become HealthTech guidance 89. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  8. Cryotherapy for the treatment of liver metastases (IPG369)

    Interventional procedures, IPG369 - Issued: December 2010 --> We have moved interventional procedures guidance 369 to become HealthTech guidance 241. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  9. Cryotherapy as a primary treatment for prostate cancer (IPG145)

    We have moved interventional procedures guidance 145 to become HealthTech guidance 91. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  10. Baricitinib for treating severe alopecia areata (TA926)

    Evidence-based recommendations on baricitinib (Olumiant) for treating severe alopecia areata in adults.

  11. superDimension Navigation System to help diagnostic sampling of peripheral lung lesions (MIB194)

    NICE has developed a medtech innovation briefing (MIB) on superDimension Navigation System to help diagnostic sampling of peripheral lung lesions .